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Abstract
Two identical isolates were recovered in pure culture from the
blood and urine of a patient suffering from severe septicaemia
associated with obstructive pyelonephritis secondary to litho-
tripsy. Preliminary phenotypic and genotypic characterizations
based on serological, biochemical and sequence analyses following
PCR ampliﬁcation of selected gene regions indicate that this
organism represents a potential new Francisella genomic species.
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The validated taxonomic organization of the family Francisella-
ceae includes only one genus, Francisella, with three species
[1]: Francisella tularensis, the cause of the zoonotic disease
tularaemia [2], Francisella novicida and Francisella philomiragia;
the latter two have limited virulence and are associated with
immunocompromised patients [3,4]. In turn, F. tularensis is
divided into three subspecies: F. tularensis ssp. tularensis
(type A), which is circulating in North America, F. tularensis
TABLE 1. Phenotypic characteristics of the isolate FhSp1 as compared with other members of the genus Francisella
Organism
Growth in different media
Antimicrobial susceptibility
expressed as MIC (mg/L)
Agglutination with anti-Ft antiserum MATa
Biochemical proﬁle
MA BA ChA FM MP AT XL TM C O U I S G
Ftt ) ) ) +48 h 1 >256 >256 0.19 + ND W ) ) ) ) +
Fth ) ) +48 h +24 h 0.5 0.38 12 0.38 + <1/4 W ) ) ) ) )
Fn ) +24 h +24 h +24 h >32 >256 >256 0.25 ) ND W ) ) ) + +
Fp ) +24 h +24 h +24 h ND ND ND ND ) ND W + ) + + )
FhSp1 ) +48 h +24 h +24 h >32 >256 >256 0.38 ) 1/4 W + ) ) + +
FhSp2 ) +48 h +24 h +24 h >32 >256 >256 0.38 ) ND W + ) ) + +
Ft, Francisella tularensis; Ftt, F. tularensis ssp. tularensis (B38); Fth, F. tularensis ssp. holarctica (LVS); Fn, Francisella novicida (U112); Fp, Francisella philomiragia (ATCC 25015); FhSp1
and FhSp2, new isolates; MA, MacConkey agar; BA, blood agar; ChA, chocolate agar; FM, Francisella medium (chocolate agar plus Isovilatex); MP, meropenem; AT, aztreonam;
XL, amoxycillin–clavulanate; TM, tobramycin; C, catalase; O, oxidase; U, urea; I, indole; S, sucrose; G, glycerol; ND, not determined..
aMicroagglutination test with inactivated F. tularensis ssp. holarctica (LVS) and the isolate FhSp1.
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FIG. 1. Phenotypic and genotypic characteristics of the isolate FhSp1 as compared with other members of the genus Francisella. (a) Protein pro-
ﬁle in 12% acrylamide gels. (b) Immunoblot analysis with the patient’s serum. (c) Ampliﬁcation of the SSTR9 element. (d) pulsed-ﬁeld gel electro-
phoresis analysis of PmEI-digested genomic DNA. Arrows indicate bands cited in the text. (a) Lane 1: Francisella tularensis ssp. holarctica (LVS).
Lane 2: F. tularensis ssp. tularensis (B38). Lane 3: Francisella novicida F·1. Lane 4: F. novicida F·2. Lane 5: F. novicida (U112). Lane 6: isolate FhSp1.
Lane 7: Francisella philomiragia (CCUG 4992). (b) Lane 1: F. philomiragia (CCUG 4992). Lane 2: F. tularensis ssp. tularensis (B38). Lane 3: F. tularensis
ssp. holarctica (LVS). Lane 4: F. novicida (U112). Lane 5: isolate FhSp1. (c) Lane 1: F. tularensis ssp. holarctica (LVS). Lane 2: F. tularensis ssp. tularensis
(B38). Lane 3: F. novicida (U112). Lane 4: isolate FhSp1. Lane 5: F. novicida F·1. (d) Lane 1: F. tularensis ssp. holarctica (LVS). Lane 2: F. tularensis
ssp. tularensis (B38). Lane 3: F. novicida F·1. Lane 4: F. novicida F·2. Lane 5: F. novicida (U112). Lane 6: isolate FhSp1. Lane 7: F. philomiragia
(CCUG 4992).
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ssp. holarctica (type B), found throughout the northern hemi-
sphere, and F. tularensis ssp. mediasiatica, distributed in east-
ern Asia and not associated with human disease. Although it
has been proposed to reclassify F. novicida as ‘F. tularensis ssp.
novicida’, this has not been validly published [5]. Also, F. philo-
miragia comprises two subspecies, philomiragia and noatunen-
sis [6]. The genus Francisella also includes organisms detected
in the environment [7], as well as the so-called Francisella-like
endosymbionts [8–14], and Wolbachia persica [1]. Addition-
ally, isolates of medical interest that do not ﬁt well into the
current taxonomic organization and cause clinical manifesta-
tions that include lymphadenopathies associated with infected
wounds, renal disease and central nervous system involve-
ment have been recently described [15,16].
We present a preliminary characterization of a pathogen
recovered from the blood and urine of a patient in Spain
that, on the basis of the data presented here, represents a
potential new Francisella species.
A 43-year-old male, with a history of repeated bilateral uro-
lithiasis, was admitted in 2003 to the Hospital Universitario in
Elche (east coast of Spain), presenting with fever, myalgia, diar-
rhoea and lower left back pain that had evolved over 7 days,
1 month after lithotripsy. The initial diagnosis was acute
obstructive pyelonephritis. Blood (ESP 384 blood culture sys-
tem; Francisco Soria Melguizo, Madrid, Spain) and urine (BBL
CLED Agar; BD Diagnostics, Madrid, Spain) cultures yielded
growth after 2 days of incubation. Empirical treatment was
started with aztreonam and amoxycillin plus clavulanate prior
to determining the antibiotic susceptibility pattern of the iso-
lates. Five days later, the patient’s condition worsened, with
high fever and pancytopenia together with coagulation altera-
tions secondary to sepsis. Consequently, the treatment was
empirically changed to tobramycin and meropenem, and the
patient recovered within 5 days. After determination of the
aetiology, the patient reported a history of handling and skin-
ning domestic rabbits, and of outdoor work and frequent
mosquito bites, but no record of having travelled abroad.
Gram stain of the isolates, named FhSp1 (= FnSp1) and
FhSp2, revealed small Gram-negative cocobacilli, and subcul-
tures of the isolates incubated on chocolate agar at 37C in
an atmosphere with 5% CO2 yielded grey mucoid colonies
after 24 h of incubation. The organisms showed no growth
on MacConkey agar. On blood agar, colonies were visible
after 48 h, whereas no growth was observed with the con-
FIG. 2. Phylogenetic analyses of 16S
rRNA (a) and a multilocus concatenated-
sequence analysis (b). In (a), the GenBank
accession numbers used are indicated,
and for (b), the following sequences
were used: AM261086–AM261089,
AM261091, AM261093, AM261097,
AM261099 and EU683021 for dnaA,
AM261181 to AM261183, AM261186 to
AM261188, AM261194, AM261196 and
EU682965 for mutS; AM261118–
AM261120, AM261123, AM261125,
AM261127, AM261128, AM261133 and
AM261203 for prfB; AM261165,
AM261167, AM261168, AM261170,
AM261177–AM261179, AM261180 and
EU682989 for putA; and AM261105,
AM261115–AM261117, AM261200,
AM261202, AM261203, AM261206 and
AM261209 for tpiA. For strains WY96-
3418 and FTA, the complete genome
sequence was used (CP000608 and
CP000803, respectively). The percent-
ages shown are those of the identity of
FhSp1 with the rest of the strains.
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trol strains B38 and LVS of F. tularensis ssp. tularensis and ssp.
holarctica, respectively, indicating differences in nutritional
requirements (Table 1).
Preliminary biochemical proﬁling yielded identical results
for both isolates. They were weakly catalase-positive and
urease-negative (as were the rest of the Francisella species
and subspecies), oxidase-positive (as was F. philomiragia, the
only species in the genus with this characteristic), indole-
negative (Wider MIC ID/GP; Francisco Soria Melguizo, SA
Madrid, Spain) and sucrose-positive and glycerol-positive
(Biolog GN2 identiﬁcation system; Biolog Inc., Hayward,
CA, USA) (Table 1). Antimicrobial sensitivity (Etest; AB
Biodisk, Tec-Laim, Madrid, Spain) of both isolates correlated
with the patient’s response to tobramycin (MIC 0.38 mg/L)
and with the inefﬁcacy of meropenem (MIC >32 mg/L),
amoxycillin–clavulanate (MIC >256 mg/L) and aztreonam
(MIC >256 mg/L) (Table 1). Their antigenic proﬁles also
showed differences from those of the other Francisella spe-
cies: with a slide agglutination method with anti-F. tularensis
immune serum (BD Diagnostics), the isolates did not agglu-
tinate; a microagglutination test [17,18] ﬁnding with the
convalescent patient’s serum (3 weeks after onset) was
negative with F. tularensis ssp. holarctica (LVS), but revealed
a titer of 1/4 with FhSp1 (Table1). The SDS-PAGE (Nu-
PAGE System; Invitrogen, Life Technologies Corporation,
Carlsbad, CA, USA) protein proﬁle of FhSp1 was also dis-
tinct from those of F. tularensis ssp. tularensis, F. tularensis
ssp. holarctica, F. novicida, (strains U112, F·1 and F·2) and
F. philomiragia (Fig. 1a). One prominent band of protein of
approximately 35 kDa was observed in FhSp1; this exhibited
apparently strong antibody binding, as compared with the
rest of the antigens, as shown by immunoblot with the
convalescent patient’s serum (Fig. 1b), performed as previ-
ously described [19]. These data revealed a phenotype of
the new isolates that was different from those of all tested
species and subspecies within the Francisella genus.
The genotypic characterization also showed differences
with respect to other Francisella reference strains. Ampliﬁca-
tion of the SSTR9 repetitive element [20] yielded a fragment
different in size from that obtained with the other species
and subspecies analysed (Fig. 1c). PCR ampliﬁcation of pdpD
[21] gave negative results, similar to what was observed with
F. tularensis ssp. holarctica (LVS) but not with F. tularensis ssp.
tularensis (B38) and F. novicida (U112) (data not shown). Also,
analysis of unsheared, PmeI-digested genomic DNA [22] using
pulsed-ﬁeld gel electrophoresis yielded a distinct genomic ﬁn-
gerprint for FhSp1 (Fig. 1d).
Phylogenetic analyses were performed after alignment of
available sequences using CLUSTAL_X [23], applying the
neighbour-joining algorithm with bootstrapping (1000 replica-
tions) [24] and using Mega4 software [25]. The analysis based
on the16S rRNA genes, sequenced as previously described
[26], grouped FhSp1 and FhSp2 (sharing an identical
sequence of 1435 bp) with the F. novicida-like isolate 3523
from Australia [15], with percentages of identity ranging
from 97.4% with the isolate MA067296, a recently described
potential new Francisella species [16], to 99.9% with iso-
late 3523 (Fig. 2a), which was recovered from a patient who
suffered a cut in brackish water, unambiguously demonstrat-
ing an afﬁliation of the two isolates with the genus Francisella.
The overall length of the aligned sequences was 1287 bp.
Furthermore, multilocus phylogenetic analysis using the con-
catenated sequences of ﬁve housekeeping genes (tpiA, dnaA,
mutS, prfB and putA; 1677 bp in total) as described previously
[27] placed strain FhSp1 in a clade separate from the other
species and subspecies of the genus for which sequence data
were available, with identities ranging from 80.20% with
F. philomiragia to 92.01% with F. tularensis ssp. tularensis
(Fig. 2b).
Nucleotide polymorphisms between FhSp1 and the rest of
species/subspecies tested in the multilocus analysis of concat-
enated sequences ranged from 332 bp (F. philomiragia) to
24 bp (strain 3523). Speciﬁcally, differences between FhSp1
and strain 3523 were observed in all ﬁve housekeeping loci
studied: dnaA (two synonymous changes), putA (two synony-
mous changes), mutS (one non synonymous change), prfB
(18 changes, 5 of them non-synonymous), and tpiA (one non-
synonymous change). Consequently, these two strains should
be considered to be different. These results support the
ascription of FhSp1 to a possible new Francisella species.
Although a preliminary study by 16S rRNA gene sequenc-
ing and biochemical proﬁling suggested that this organism
belongs to the group of atypical F. novicida-like organisms,
the results presented here support the separate ascription of
FhSp1 to a potential new species in the Francisella genus.
Additionally, we have developed a molecular detection
method for the speciﬁc identiﬁcation of FhSp1 [11]. Further
studies concerning both the geographical distribution and the
relevance of this organism in terms of public health, as well
as its taxonomic position, are being conducted. Its recovery
in pure culture from both blood and urine supports the
assumption that this organism is responsible for severe ill-
ness in a previously healthy, immunocompetent patient.
Indeed, health professionals should be careful when an
organism with similar characteristics is isolated in their rou-
tine practice, and ensure its identiﬁcation for the proper
treatment of patients.
The nucleotide sequences determined in this study have
been submitted to GenBank under the following accession
numbers: FJ997642 and GQ149488 for 16S rRNA of FhSp1 and
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FhSp2, respectively; FJ981647 (dnaA), FJ981649 (mutS),
FJ981650 (prfB), FJ981651 (putA) and FJ981652 (tpiA) for FhSp1;
and GQ411396 (dnaA), GQ411397 (putA), GQ411398 (mutS),
GQ411399 (prfB) and GQ411400 (tpiA) for strain 3523.
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